Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort Study

被引:3
|
作者
Nam, Bora [1 ,2 ]
Sung, Yoon-Kyoung [1 ,2 ]
Choi, Chan-Bum [1 ,2 ]
Kim, Tae-Hwan [1 ,2 ]
Jun, Jae-Bum [1 ,2 ]
Bae, Sang-Cheol [1 ,2 ]
Yoo, Dae-Hyun [1 ,2 ]
Cho, Soo-Kyung [1 ,2 ]
机构
[1] Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, 222-1 Wangsimni Ro, Seoul 04763, South Korea
[2] Hanyang Univ, Inst Rheumatol Res, Seoul, South Korea
关键词
Polymyalgia Rheumatica; Fracture; Osteoporosis; Bone Mineral Density; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; RHEUMATISM/AMERICAN COLLEGE; PROGNOSTIC-FACTORS; EUROPEAN LEAGUE; EPIDEMIOLOGY; DISPARITIES; PREVALENCE; MANAGEMENT; DIAGNOSIS; DISEASES;
D O I
10.3346/jkms.2021.36.e263
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To evaluate the incidence of fractures and fracture risk factors in Korean patients with polymyalgia rheumatica (PMR). Methods: All PMR patients who visited a rheumatology clinic at a tertiary referral hospital between March 2005 and March 2018 were retrospectively assessed. We estimated bone mineral density (BMD) screening rate within 6 months of the first visit and classified the patients according to the performance and results of BMD screening. Incidence rates (IRs) of fractures were calculated in each group and risk factors for fractures were identified using Poisson regression analysis. Results: A total of 95 PMR patients with median (interquartile range) age of 64.0 (56.0-72.0) years were included. Baseline BMD was assessed in only 55.8% of these patients (n = 53); 24 patients with osteoporosis, 20 with osteopenia, and 9 with normal BMD. During 433.1 person-years (PYs) of observation, 17 fractures occurred in 12 patients (IR, 3.93 [95% confidence interval (CI), 2.46-6.26]/100 PYs); 8.32 (95% CI, 4.09-16.90)/100 PYs in the osteopenia group, 3.40 (95% CI, 1.30-8.90)/100 PYs in the osteoporosis group, and 3.37 (95% CI, 1.53-7.39)/100 PYs in the no BMD test group. Risk factors for fractures were female sex, advanced age (>_ 65 years), longer follow-up duration, initial glucocorticoid dose >_ 10 mg/day, and higher cumulative glucocorticoid dose over the first 6 months. Conclusion: The incidence rate of fractures in Korean patients with PMR was 3.93/100 PYs. Female sex, advanced age, longer follow-up duration, and increased glucocorticoid dose are risk factors for osteoporotic fracture.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Fracture risk of patients suffering from dizziness: A retrospective cohort study
    Kruschinski, Carsten
    Sheehy, Odile
    Hummers-Pradier, Eva
    Lelorier, Jacques
    EUROPEAN JOURNAL OF GENERAL PRACTICE, 2010, 16 (04) : 229 - 235
  • [42] Effect of add-on methotrexate in polymyalgia rheumatica patients flaring on glucocorticoids tapering: a retrospective study
    Diane Marsman
    Thomas Bolhuis
    Nathan den Broeder
    Frank van den Hoogen
    Alfons den Broeder
    Aatke van der Maas
    Rheumatology International, 2021, 41 : 611 - 616
  • [43] GIANT-CELL ARTERITIS, TEMPORAL ARTERITIS AND POLYMYALGIA RHEUMATICA - RETROSPECTIVE STUDY OF 63 PATIENTS
    SORENSEN, PS
    LORENZEN, I
    ACTA MEDICA SCANDINAVICA, 1977, 201 (03): : 207 - 213
  • [44] Effect of add-on methotrexate in polymyalgia rheumatica patients flaring on glucocorticoids tapering: a retrospective study
    Marsman, Diane
    Bolhuis, Thomas
    Broeder, Nathan den
    van den Hoogen, Frank
    den Broeder, Alfons
    van der Maas, Aatke
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (03) : 611 - 616
  • [45] POLYMYALGIA RHEUMATICA - CLINICAL-STUDY OF 17 PATIENTS
    ANDRADA, SS
    PEREZ, JM
    SAGREDO, JLP
    MARTINEZ, JO
    VALVERDE, VR
    MEDICINA CLINICA, 1981, 77 (09): : 361 - 366
  • [46] Risk for neurodegenerative disorders in Korean patients with vitiligo: A nationwide retrospective cohort study
    Kim, Tae-Gyun
    Shin, Jaeyong
    Hwang, Shinwon
    Lee, Si-Hyung
    Kim, Hyeon Chang
    Oh, Sang Ho
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (02) : 621 - 623
  • [47] PREDICTING DURATION OF GLUCOCORTICOID THERAPY IN AN INCEPTION COHORT OF PATIENTS WITH POLYMYALGIA RHEUMATICA
    Morton, Chris
    Muller, Sara
    Hider, Samantha
    Belcher, John
    Mallen, Christian D.
    Helliwell, Toby
    RHEUMATOLOGY, 2019, 58 : 176 - 176
  • [48] TREATMENT OF POLYMYALGIA RHEUMATICA WITH TOCILIZUMAB: RESULTS OF AN OBSERVATIONAL RETROSPECTIVE MULTICENTER STUDY
    Assaraf, M.
    Chevet, B.
    Philippe, P.
    Avouac, J.
    Delacour, M.
    Houvenagel, E.
    Pascart, T.
    Henry, J.
    Roux, C.
    Wendling, D.
    Paccou, J.
    Cortet, B.
    Devauchelle-Pensec, V.
    Flipo, R. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 662 - 662
  • [49] Patients' views on the causes of their polymyalgia rheumatica: a content analysis of data from the PMR Cohort Study
    Tshimologo, Maatla
    Saunders, Benjamin
    Muller, Sara
    Mallen, Christian D.
    Hider, Samantha L.
    BMJ OPEN, 2017, 7 (01):
  • [50] Fracture patterns in type 1 diabetes and their associated risk factors: a retrospective cohort study
    Rasmussen, N. H.
    Driessen, J. H. M.
    Kvist, A. Vestergaard
    Brodersen, M.
    Kaldahl, L. Rosengren
    Leegaard, I.
    Souverein, P. C.
    van den Bergh, J.
    Vestergaard, P.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S198 - S199